Effect of sex on aging-related decline of dopamine transporter in healthy subjects

[1]  Christine L. Tardif,et al.  MR‐based age‐related effects on the striatum, globus pallidus, and thalamus in healthy individuals across the adult lifespan , 2019, Human brain mapping.

[2]  B. S. Ye,et al.  Beneficial effect of estrogen on nigrostriatal dopaminergic neurons in drug-naïve postmenopausal Parkinson’s disease , 2019, Scientific Reports.

[3]  Alan J. Thomas,et al.  123I-FP-CIT striatal binding ratios do not decrease significantly with age in older adults , 2019, Annals of Nuclear Medicine.

[4]  J. Hatazawa,et al.  Japanese multicenter database of healthy controls for [123I]FP-CIT SPECT , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  Sahil Bajaj,et al.  Brain Aging: Uncovering Cortical Characteristics of Healthy Aging in Young Adults , 2017, Front. Aging Neurosci..

[6]  S. Ray,et al.  Neuroprotective effects of estrogen in CNS injuries: insights from animal models , 2017, Neuroscience and neuroeconomics.

[7]  S. Aoki,et al.  Age-related effects and gender differences in Japanese healthy controls for [123I] FP-CIT SPECT , 2017, Annals of Nuclear Medicine.

[8]  A. Rodriguez-Perez,et al.  Menopause and Parkinson’s disease. Interaction between estrogens and brain renin-angiotensin system in dopaminergic degeneration , 2016, Frontiers in Neuroendocrinology.

[9]  M. Labanowski.  Neuroanatomy, Mesencephalon, Midbrain , 2015 .

[10]  D. Ros,et al.  Dopamine transporter imaging in the aged rat: a [¹²³I]FP-CIT SPECT study. , 2015, Nuclear medicine and biology.

[11]  Y. Okubo,et al.  Age-related decline in dopamine transporter in human brain using PET with a new radioligand [18F]FE-PE2I , 2014, Annals of Nuclear Medicine.

[12]  Wolfram Schultz,et al.  The role of the striatum in social behavior , 2013, Front. Neurosci..

[13]  F. Carrillo,et al.  [Elaboration of the SPM template for the standardization of SPECT images with 123I-Ioflupane] , 2013 .

[14]  J. Darcourt,et al.  No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT , 2013, EJNMMI Research.

[15]  J. Darcourt,et al.  Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  E. Park.  A New Era of Clinical Dopamine Transporter Imaging Using 123I-FP-CIT* , 2012, The Journal of Nuclear Medicine Technology.

[17]  A. Eusebio,et al.  Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  A. Singleton,et al.  The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.

[19]  Mark Jenkinson,et al.  Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy , 2011, NeuroImage.

[20]  A. Gogos,et al.  The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: An autoradiography study , 2010, Brain Research.

[21]  G. Fisone,et al.  Signaling in the basal ganglia: Postsynaptic and presynaptic mechanisms , 2007, Physiology & Behavior.

[22]  R. Peters,et al.  Ageing and the brain , 2006, Postgraduate Medical Journal.

[23]  Cheryl L. Dahle,et al.  Regional brain changes in aging healthy adults: general trends, individual differences and modifiers. , 2005, Cerebral cortex.

[24]  E. Ryding,et al.  A new model for separation between brain dopamine and serotonin transporters in 123I-β-CIT SPECT measurements: normal values and sex and age dependence , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  Faith M. Gunning-Dixon,et al.  Differential aging of the human striatum: longitudinal evidence. , 2003, AJNR. American journal of neuroradiology.

[26]  Nick C Fox,et al.  A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. , 2003, Archives of neurology.

[27]  M. Fischer,et al.  Renin angiotensin system and gender differences in the cardiovascular system. , 2002, Cardiovascular research.

[28]  L. Reneman,et al.  Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers , 2000, European Journal of Nuclear Medicine.

[29]  Janet R. Saffer,et al.  Effects of age on dopamine transporters in healthy humans. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  T. Di Paolo,et al.  Ovariectomy and estradiol treatment affect the dopamine transporter and its gene expression in the rat brain. , 1997, Brain research. Molecular brain research.

[31]  D. Charney,et al.  Age-Related Decline in Striatal Dopamine Transporter Binding with Iodine-123-β-CITSPECT , 1995 .

[32]  A. Lees,et al.  Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.

[33]  K. Laere,et al.  European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  T. Travison,et al.  A population-level decline in serum testosterone levels in American men. , 2007, The Journal of clinical endocrinology and metabolism.

[35]  J. Seibyl,et al.  Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[36]  J. Seibyl,et al.  Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[37]  R. Rubens,et al.  Plasma testosterone levels in women in normal and pathological conditions , 1971 .